Clinical Applications Targeting Periostin

Akira Kudo

doi:10.1007/978-981-13-6657-4_19

Clinical Applications Targeting Periostin

Adv Exp Med Biol. 2019:1132:207-210. doi: 10.1007/978-981-13-6657-4_19.

Author

Akira Kudo^{1

2}

Affiliations

¹ International Frontier, Tokyo Institute of Technology, Meguro-ku, Tokyo, Japan. [email protected].
² School of Dentistry, Showa University, Tokyo, Japan. [email protected].

PMID: 31037637
DOI: 10.1007/978-981-13-6657-4_19

Abstract

Since periostin is expressed and functioned in incredible diseases , clinical applications have been initiated to directly target periostin for inhibition or activation, or periostin expression is utilized to indicate the disease state or a marker for curing diseases, which will provide novel methods in clinical applications.

Keywords: Biomaterials; Capsular contraction; Clinical application; DNA aptamer; Incredible disease; Lebrikizumab; Osteoporosis; Periostin antibody; RNAi.

Publication types

Review

MeSH terms

Biomarkers
Cell Adhesion Molecules / physiology*
Disease
Humans
Molecular Targeted Therapy*

Substances

Biomarkers
Cell Adhesion Molecules
POSTN protein, human